Publication

Rapid risk assessment: Severe respiratory disease associated with Middle East respiratory syndrome coronavirus (MERS-CoV). 19th update, 31 July 2015

Risk assessment -

Publication

Achievements, challenges and major outputs 2014: Highlights from the Annual Report of the Director

Corporate publication -

Publication

Communicable disease threats report, Week 31, 26 July - 1 August 2015

Surveillance report -

Publication

Rapid risk assessment: Cutaneous diphtheria among recently arrived refugees and asylum-seekers in the EU, 31 July 2015

Risk assessment -

Publication

Influenza virus characterisation, Summary Europe, June 2015

Surveillance report -
There are currently no items to display

Data

Table. Number of measles cases by month and notification rate (cases per million) by country, January 2015 to December 2015, EU/EEA countries

Table -

Data

Measles notification rate, November 2014 to October 2015

Map -

Data

Measles vaccination rate, second dose, 2013-2014, and the number of cases, October 2015

Map -

Data

Antimicrobial resistance of microorganisms reported in healthcare-associated infections

Infographic -

Data

Healthcare-associated infections in European hospitals

Infographic -

Event

Meeting of ECDC Focal Points in the global Centres for Disease Control

3 Jun 2019
Stockholm, Sweden

Event

ECDC Summer School 2019

10 Jun 2019 - 14 Jun 2019
Stockholm, Sweden

Event

Joint Meeting of the National Focal Points for Preparedness and Response and for Threat Detection, EWRS and IHR

23 May 2019 - 24 May 2019
Stockholm, Sweden

Event

Annual meeting of the Technical Advisory Committee for the European Antibiotic Awareness day (EAAD)

22 May 2019 - 24 May 2019
ECDC, Stockholm

Active threats and outbreaks

Ebola virus disease in the Democratic Republic of the Congo (North Kivu and Ituri)
The number of cases and affected areas continues to increase. It is unlikely that the outbreak will be controlled in the near future. Find out more

Measles
Large outbreaks with fatalities are ongoing in EU countries that had previously eliminated or interrupted endemic transmission. Find out more